Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cytokinetics Inc (CYTK)  
$53.78 2.03 (3.92%) as of 4:30 Thu 6/27


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 122,563,000
Market Cap: 6.59(B)
Last Volume: 8,264,325 Avg Vol: 8,242,049
52 Week Range: $26.88 - $108.06
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 138,093 288,980 461,958 926,280
Total Sell Value $8,135,395 $19,867,810 $25,677,895 $46,442,456
Total People Sold 7 8 8 12
Total Sell Transactions 11 21 41 87
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 1115
  Page 42 of 45  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sabry James H President and CEO   •       •      –    2006-05-01 4 AS $7.13 $50,276 D/D (7,000) 0     -
   Sabry James H President and CEO   •       •      –    2006-05-01 4 OE $0.58 $4,060 D/D 7,000 7,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2006-04-17 4 AS $7.34 $35,555 D/D (4,844) 65,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2006-04-17 4 OE $0.58 $2,810 D/D 4,844 69,844     -
   Trautman Jay K VP, Disc Biology & Technology   •       –      –    2006-04-17 4 AS $7.34 $7,340 D/D (1,000) 28,160     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2006-04-17 4 AS $7.34 $36,700 D/D (5,000) 20,000     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2006-04-17 4 OE $1.00 $5,000 D/D 5,000 25,000     -
   Spudich James A Director   –       •      –    2006-04-04 4 AS $7.59 $16,730 D/D (2,200) 233,400     -
   Sabry James H President and CEO   •       •      –    2006-04-03 4 AS $7.43 $51,658 D/D (6,823) 0     -
   Sabry James H President and CEO   •       •      –    2006-04-03 4 OE $0.58 $3,957 D/D 6,823 123     -
   Sabry James H President and CEO   •       •      –    2006-04-03 4 AS $7.65 $1,354 D/D (177) 0     -
   Sabry James H President and CEO   •       •      –    2006-04-03 4 OE $0.58 $103 D/D 177 177     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2006-03-30 4 AS $7.06 $33,097 D/D (4,688) 65,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2006-03-30 4 OE $0.58 $2,719 D/D 4,688 69,688     -
   Trautman Jay K VP, Disc Biology & Technology   •       –      –    2006-03-15 4 AS $7.01 $7,010 D/D (1,000) 29,160     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2006-03-15 4 AS $7.01 $30,669 D/D (4,375) 65,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2006-03-15 4 OE $0.58 $2,538 D/D 4,375 69,375     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2006-03-15 4 AS $7.01 $35,050 D/D (5,000) 20,000     -
   Morgans David J Jr SVP-Drug Discovery and Dev   •       –      –    2006-03-15 4 OE $1.00 $5,000 D/D 5,000 25,000     -
   Spudich James A Director   –       •      –    2006-03-02 4 AS $7.06 $15,606 D/D (2,200) 235,600     -
   Sabry James H President and CEO   •       •      –    2006-03-01 4 AS $7.13 $50,048 D/D (7,000) 0     -
   Sabry James H President and CEO   •       •      –    2006-03-01 4 OE $0.58 $4,060 D/D 7,000 83     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2006-02-28 4 AS $7.10 $26,625 D/D (3,750) 65,000     -
   Blum Robert I EVP, Corp. Development & CBO   •       –      –    2006-02-28 4 OE $0.58 $2,175 D/D 3,750 68,750     -
   Dow Stephen M Director   –       •       •   2006-02-16 4 B $7.49 $43,466 I/I 5,800 125,000 2.25     -
  1115 Records found
  Previous  40  41  42  43  44  45   
  Page 42 of 45
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us